vs
C3.ai, Inc.（AI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
C3.ai, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.1倍（$75.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -139.3%，领先523.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -20.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -2.1%）
C3.ai是全球领先的企业级人工智能软件供应商，主要开发销售可扩展的AI应用、平台工具及垂直行业定制解决方案，服务覆盖制造、能源、金融、医疗、公共部门等领域，助力客户优化运营、降本增效、管控风险，实现数据驱动的业务决策。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AI vs RIGL — 直观对比
营收规模更大
AI
是对方的1.1倍
$69.8M
营收增速更快
RIGL
高出41.5%
-20.3%
净利率更高
RIGL
高出523.3%
-139.3%
两年增速更快
RIGL
近两年复合增速
-2.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.1M | $69.8M |
| 净利润 | $-104.7M | $268.1M |
| 毛利率 | 40.4% | 91.5% |
| 营业利润率 | -149.2% | 33.2% |
| 净利率 | -139.3% | 384.0% |
| 营收同比 | -20.3% | 21.2% |
| 净利润同比 | -58.7% | 1769.2% |
| 每股收益（稀释后） | $-0.75 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AIRIGL
| Q4 25 | $75.1M | $69.8M | ||
| Q3 25 | $70.3M | $69.5M | ||
| Q2 25 | $108.7M | $101.7M | ||
| Q1 25 | $98.8M | $53.3M | ||
| Q4 24 | $94.3M | $57.6M | ||
| Q3 24 | $87.2M | $55.3M | ||
| Q2 24 | $86.6M | $36.8M | ||
| Q1 24 | $78.4M | $29.5M |
净利润AIRIGL
| Q4 25 | $-104.7M | $268.1M | ||
| Q3 25 | $-116.8M | $27.9M | ||
| Q2 25 | $-79.7M | $59.6M | ||
| Q1 25 | $-80.2M | $11.4M | ||
| Q4 24 | $-66.0M | $14.3M | ||
| Q3 24 | $-62.8M | $12.4M | ||
| Q2 24 | $-72.9M | $-1.0M | ||
| Q1 24 | $-72.6M | $-8.2M |
毛利率AIRIGL
| Q4 25 | 40.4% | 91.5% | ||
| Q3 25 | 37.6% | 93.2% | ||
| Q2 25 | 62.1% | 95.6% | ||
| Q1 25 | 59.1% | 91.7% | ||
| Q4 24 | 61.3% | 89.9% | ||
| Q3 24 | 59.8% | 85.5% | ||
| Q2 24 | 59.6% | 92.4% | ||
| Q1 24 | 57.8% | 93.1% |
营业利润率AIRIGL
| Q4 25 | -149.2% | 33.2% | ||
| Q3 25 | -177.7% | 40.9% | ||
| Q2 25 | -81.8% | 60.1% | ||
| Q1 25 | -88.7% | 23.9% | ||
| Q4 24 | -79.8% | 28.9% | ||
| Q3 24 | -83.2% | 25.4% | ||
| Q2 24 | -95.1% | 1.2% | ||
| Q1 24 | -105.3% | -23.6% |
净利率AIRIGL
| Q4 25 | -139.3% | 384.0% | ||
| Q3 25 | -166.2% | 40.2% | ||
| Q2 25 | -73.3% | 58.6% | ||
| Q1 25 | -81.2% | 21.5% | ||
| Q4 24 | -69.9% | 24.9% | ||
| Q3 24 | -72.0% | 22.5% | ||
| Q2 24 | -84.2% | -2.8% | ||
| Q1 24 | -92.6% | -27.9% |
每股收益（稀释后）AIRIGL
| Q4 25 | $-0.75 | $14.11 | ||
| Q3 25 | $-0.86 | $1.46 | ||
| Q2 25 | $-0.60 | $3.28 | ||
| Q1 25 | $-0.62 | $0.63 | ||
| Q4 24 | $-0.52 | $0.82 | ||
| Q3 24 | $-0.50 | $0.70 | ||
| Q2 24 | $-0.59 | $-0.06 | ||
| Q1 24 | $-0.60 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $675.0M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $771.9M | $391.5M |
| 总资产 | $961.3M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AIRIGL
| Q4 25 | $675.0M | $155.0M | ||
| Q3 25 | $711.9M | $137.1M | ||
| Q2 25 | $742.7M | $108.4M | ||
| Q1 25 | $724.3M | $77.1M | ||
| Q4 24 | $730.4M | $77.3M | ||
| Q3 24 | $762.5M | $61.1M | ||
| Q2 24 | $750.4M | $49.1M | ||
| Q1 24 | $723.3M | $49.5M |
总债务AIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AIRIGL
| Q4 25 | $771.9M | $391.5M | ||
| Q3 25 | $798.8M | $117.6M | ||
| Q2 25 | $838.3M | $81.9M | ||
| Q1 25 | $860.2M | $18.6M | ||
| Q4 24 | $859.0M | $3.3M | ||
| Q3 24 | $874.9M | $-14.6M | ||
| Q2 24 | $873.4M | $-29.9M | ||
| Q1 24 | $898.0M | $-31.7M |
总资产AIRIGL
| Q4 25 | $961.3M | $513.6M | ||
| Q3 25 | $968.7M | $242.5M | ||
| Q2 25 | $1.0B | $206.7M | ||
| Q1 25 | $1.1B | $176.0M | ||
| Q4 24 | $1.0B | $164.0M | ||
| Q3 24 | $1.1B | $139.4M | ||
| Q2 24 | $1.0B | $128.4M | ||
| Q1 24 | $1.1B | $126.5M |
负债/权益比AIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-46.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-46.9M | — |
| 自由现金流率自由现金流/营收 | -62.4% | — |
| 资本支出强度资本支出/营收 | 0.5% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-93.2M | — |
8季度趋势，按日历期对齐
经营现金流AIRIGL
| Q4 25 | $-46.5M | $22.0M | ||
| Q3 25 | $-33.5M | $24.0M | ||
| Q2 25 | $11.3M | $30.5M | ||
| Q1 25 | $-22.0M | $-893.0K | ||
| Q4 24 | $-38.7M | $14.5M | ||
| Q3 24 | $8.0M | $21.7M | ||
| Q2 24 | $21.3M | $302.0K | ||
| Q1 24 | $-39.1M | $-5.0M |
自由现金流AIRIGL
| Q4 25 | $-46.9M | — | ||
| Q3 25 | $-34.3M | — | ||
| Q2 25 | $10.3M | — | ||
| Q1 25 | $-22.4M | — | ||
| Q4 24 | $-39.5M | — | ||
| Q3 24 | $7.1M | — | ||
| Q2 24 | $18.8M | — | ||
| Q1 24 | $-45.1M | — |
自由现金流率AIRIGL
| Q4 25 | -62.4% | — | ||
| Q3 25 | -48.8% | — | ||
| Q2 25 | 9.5% | — | ||
| Q1 25 | -22.7% | — | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | 21.7% | — | ||
| Q1 24 | -57.6% | — |
资本支出强度AIRIGL
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 7.8% | — |
现金转化率AIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AI
| License And Service | $70.2M | 93% |
| Professional Services | $4.9M | 7% |
RIGL
暂无分部数据
